Entia Biosciences, Inc.

CIK 1408299 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Entia Biosciences, Inc..

Recent SEC filings

FiledFormAccession number
Feb 11, 201915-12G/A0001185185-19-000203
Dec 19, 201815-12G0001185185-18-002195
Sep 7, 20188-K0001185185-18-001656
Apr 20, 20188-K0001185185-18-000731
Mar 30, 20188-K0001185185-18-000556
Dec 4, 20178-K0001185185-17-002538
Sep 5, 2017CT ORDER9999999997-17-008490
May 19, 201710-K0001185185-17-001225
May 15, 2017NT 10-Q0001185185-17-001151
Mar 31, 2017NT 10-K0001185185-17-000762
Mar 2, 2017DEF 14A0001185185-17-000506
Feb 24, 20178-K0001185185-17-000445
Feb 17, 2017PRE 14A0001185185-17-000415
Feb 16, 201740001185185-17-000392
Feb 16, 201740001185185-17-000386
Feb 16, 201740001185185-17-000390
Feb 16, 201740001185185-17-000388
Dec 9, 20168-K0001185185-16-005923
Dec 6, 201640001185185-16-005908
Nov 14, 201610-Q0001185185-16-005749
Nov 2, 20168-K0001185185-16-005633
Sep 29, 201610-Q0001185185-16-005516
Sep 28, 20168-K0001185185-16-005512
Aug 25, 20168-K0001185185-16-005339
Aug 16, 2016NT 10-Q0001185185-16-005245